114 related articles for article (PubMed ID: 2278995)
1. Amelioration of intrathymic T cell development and peripheral T cell reactivities in autoimmune mice undergoing therapy with a novel immunomodulator.
Spetz-Hagberg AL; Goldschmidt TJ; Stålhandske T; Larsson-Sciard EL
Int Immunol; 1990; 2(7):645-50. PubMed ID: 2278995
[TBL] [Abstract][Full Text] [Related]
2. Decreased levels of pathogenic IgG anti-DNA antibodies in autoimmune mice after linomide treatment.
Spetz-Hagberg AL; Larsson-Sciard EL
Res Immunol; 1989; 140(5-6):517-25. PubMed ID: 2789418
[TBL] [Abstract][Full Text] [Related]
3. Liver is a possible site for the proliferation of abnormal CD3+4-8- double-negative lymphocytes in autoimmune MRL-lpr/lpr mice.
Ohteki T; Seki S; Abo T; Kumagai K
J Exp Med; 1990 Jul; 172(1):7-12. PubMed ID: 2141631
[TBL] [Abstract][Full Text] [Related]
4. Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse.
Zhou T; Bluethmann H; Eldridge J; Berry K; Mountz JD
J Immunol; 1993 Apr; 150(8 Pt 1):3651-67. PubMed ID: 7682246
[TBL] [Abstract][Full Text] [Related]
5. Effects of immunomodulating treatment on autoimmune sialadenitis in MRL/Mp-lpr/lpr mice.
Jonsson R; Tarkowski A; Bäckman K
Agents Actions; 1988 Dec; 25(3-4):368-74. PubMed ID: 3218611
[TBL] [Abstract][Full Text] [Related]
6. T cell lineages in the thymus of lpr/lpr mice. Evidence for parallel pathways of normal and abnormal T cell development.
Budd RC; Schreyer M; Miescher GC; MacDonald HR
J Immunol; 1987 Oct; 139(7):2200-10. PubMed ID: 3498754
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of self-reactive T cell receptor V beta regions in autoimmune mice.
Mountz JD; Smith TM; Toth KS
J Immunol; 1990 Mar; 144(6):2159-66. PubMed ID: 1690237
[TBL] [Abstract][Full Text] [Related]
8. Autoreactivity accelerates the development of autoimmunity and lymphoproliferation in MRL/Mp-lpr/lpr mice.
Weston KM; Yeh ET; Sy MS
J Immunol; 1987 Aug; 139(3):734-42. PubMed ID: 3110283
[TBL] [Abstract][Full Text] [Related]
9. Thymic influences on autoimmunity in MRL-lpr mice.
Wofsy D; Ledbetter JA; Roubinian JR; Seaman WE; Talal N
Scand J Immunol; 1982 Jul; 16(1):51-8. PubMed ID: 6981841
[TBL] [Abstract][Full Text] [Related]
10. Intestinal intraepithelial lymphocyte T cells are resistant to lpr gene-induced T cell abnormalities.
Aicher WK; Fujihashi K; Taguchi T; McGhee JR; Yamamoto M; Eldridge JH; Gay S; Kiyono H
Eur J Immunol; 1992 Jan; 22(1):137-45. PubMed ID: 1346108
[TBL] [Abstract][Full Text] [Related]
11. beta2-microglobulin dependence of the lupus-like autoimmune syndrome of MRL-lpr mice.
Christianson GJ; Blankenburg RL; Duffy TM; Panka D; Roths JB; Marshak-Rothstein A; Roopenian DC
J Immunol; 1996 Jun; 156(12):4932-9. PubMed ID: 8648144
[TBL] [Abstract][Full Text] [Related]
12. The effect of immunomodulating treatment on cutaneous delayed-type hypersensitivity in MRL lpr/lpr mice.
Carlsten H; Tarkowski A; Nilsson LA
APMIS; 1989 Aug; 97(8):728-32. PubMed ID: 2788441
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune CD4+ T cells interfere with immune tolerance to a thymic-independent antigen.
Miller ML; Chacko JA
J Immunol; 1988 Jun; 140(12):4108-14. PubMed ID: 3286767
[TBL] [Abstract][Full Text] [Related]
14. Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype.
Prud'Homme GJ; Park CL; Fieser TM; Kofler R; Dixon FJ; Theofilopoulos AN
J Exp Med; 1983 Feb; 157(2):730-42. PubMed ID: 6600490
[TBL] [Abstract][Full Text] [Related]
15. Oncogene expression in autoimmune mice.
Mountz JD; Mushinski JF; Mark GE; Steinberg AD
J Mol Cell Immunol; 1985; 2(3):121-31. PubMed ID: 3916923
[TBL] [Abstract][Full Text] [Related]
16. Treatment of autoimmune MRL/Ipr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease.
Seaman WE; Wofsy D; Greenspan JS; Ledbetter JA
J Immunol; 1983 Apr; 130(4):1713-8. PubMed ID: 6187819
[TBL] [Abstract][Full Text] [Related]
17. T cells of staphylococcal enterotoxin B-tolerized autoimmune MRL-lpr/lpr mice require co-stimulation through the B7-CD28/CTLA-4 pathway for activation and can be reanergized in vivo by stimulation of the T cell receptor in the absence of this co-stimulatory signal.
Zhou T; Weaver C; Linsley PS; Mountz JD
Eur J Immunol; 1994 May; 24(5):1019-25. PubMed ID: 7514125
[TBL] [Abstract][Full Text] [Related]
18. Diethyldithiocarbamate, a novel immunomodulator, prolongs survival in autoimmune MRL-lpr/lpr mice.
Halpern MD; Hersh E; Yocum DE
Clin Immunol Immunopathol; 1990 May; 55(2):242-54. PubMed ID: 2157571
[TBL] [Abstract][Full Text] [Related]
19. Transgenic rearranged T cell receptor gene inhibits lymphadenopathy and accumulation of CD4-CD8-B220+ T cells in lpr/lpr mice.
Mountz JD; Zhou T; Eldridge J; Berry K; Blüthmann H
J Exp Med; 1990 Dec; 172(6):1805-17. PubMed ID: 1701823
[TBL] [Abstract][Full Text] [Related]
20. IL-2 receptor expression in autoimmune MRL-lpr/lpr mice. The expanded L3T4-, Lyt-2- population does not express p75 and cannot generate functional high-affinity IL-2 receptors.
Rosenberg YJ; Nurse F; Begley CG
J Immunol; 1989 Oct; 143(7):2216-22. PubMed ID: 2789257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
